Demonstrates the feasibility and current limitations of using a comprehensive suite of personal sensors to continuously measure the exposome and acute health responses.
Supports 24-h personal exposome monitoring feasibility; leaves open larger-scale use until wearability, battery life, and cost improve.
No takes yet. Share an insight, caveat, or question.
Nieuwenhuijsen et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: